Search hospitals > Georgia > Athens
University Cancer and Blood Center LLC
Claim this profileAthens, Georgia 30607
Global Leader in Non-Small Cell Lung Cancer
Global Leader in Cancer
Conducts research for Breast Cancer
Conducts research for Lung Cancer
Conducts research for Tumors
165 reported clinical trials
6 medical researchers
Summary
University Cancer and Blood Center LLC is a medical facility located in Athens, Georgia. This center is recognized for care of Non-Small Cell Lung Cancer, Cancer, Breast Cancer, Lung Cancer, Tumors and other specialties. University Cancer and Blood Center LLC is involved with conducting 165 clinical trials across 180 conditions. There are 6 research doctors associated with this hospital, such as Sharad Ghamande, Petros Nikolinakos, Gustavo Westin, MD, and Kuang Chang, MD.Area of expertise
1Non-Small Cell Lung Cancer
Global LeaderStage IV
Stage III
Stage II
2Cancer
Global LeaderStage IV
Stage III
Stage I
Top PIs
Sharad GhamandeAugusta University Medical Center1 year of reported clinical research
Expert in Cancer
Expert in Breast Cancer
69 reported clinical trials
146 drugs studied
Petros NikolinakosUniversity Cancer & Blood Center5 years of reported clinical research
Studies Prostate Cancer
Studies Non-Small Cell Lung Cancer
16 reported clinical trials
36 drugs studied
Gustavo Westin, MDUniversity Cancer & Blood Center4 years of reported clinical research
Studies Non-Small Cell Lung Cancer
Studies Breast Cancer
6 reported clinical trials
12 drugs studied
Kuang Chang, MDUniversity Cancer & Blood Center, LLC6 years of reported clinical research
Studies Non-Small Cell Lung Cancer
Studies Melanoma
4 reported clinical trials
11 drugs studied
Clinical Trials running at University Cancer and Blood Center LLC
Breast Cancer
Non-Small Cell Lung Cancer
Lung Cancer
Cancer
Colorectal Cancer
Squamous Cell Carcinoma
Tumors
Pancreatic Cancer
Multiple Myeloma
Solid Tumors
Sacituzumab Govitecan + Pembrolizumab
for Triple Negative Breast Cancer
The goal of this study is to find out if the experimental product, sacituzumab govitecan-hziy (SG) in combination with pembrolizumab given after surgery, is effective and safe compared to the treatment of physician's choice (TPC) which includes either pembrolizumab or pembrolizumab plus capecitabine in participants with triple negative breast cancer that still remains after surgery and pre-surgical treatment.
Recruiting2 awards Phase 36 criteria
T-DM1 + Tucatinib
for Breast Cancer
This phase III trial studies how well trastuzumab emtansine (T-DM1) and tucatinib work in preventing breast cancer from coming back (relapsing) in patients with high risk, HER2 positive breast cancer. T-DM1 is a monoclonal antibody, called trastuzumab, linked to a chemotherapy drug, called DM1. Trastuzumab is a form of targeted therapy because it attaches to specific molecules (receptors) on the surface of cancer cells, known as HER2 receptors, and delivers DM1 to kill them. Tucatinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving T-DM1 and tucatinib may work better in preventing breast cancer from relapsing in patients with HER2 positive breast cancer compared to T-DM1 alone.
Recruiting1 award Phase 313 criteria
Atezolizumab + Trastuzumab Emtansine
for Breast Cancer
This is a Phase III, two-arm, randomized, double-blind placebo-controlled study in participants with HER2-positive primary breast cancer who have received preoperative chemotherapy and HER2-directed therapy, including trastuzumab followed by surgery, with a finding of residual invasive disease in the breast and/or axillary lymph nodes. As of June 4, 2024, this study is no longer accepting any newly screened participants.
Recruiting1 award Phase 35 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at University Cancer and Blood Center LLC?
University Cancer and Blood Center LLC is a medical facility located in Athens, Georgia. This center is recognized for care of Non-Small Cell Lung Cancer, Cancer, Breast Cancer, Lung Cancer, Tumors and other specialties. University Cancer and Blood Center LLC is involved with conducting 165 clinical trials across 180 conditions. There are 6 research doctors associated with this hospital, such as Sharad Ghamande, Petros Nikolinakos, Gustavo Westin, MD, and Kuang Chang, MD.